Company Email Format Management

Kymera Therapeutics

Biotechnology Research 500 North Beacon Street 250 employees

Employees: 250
Contacts: 4
Emails: 4
Phones: 4

kymeratx.com LinkedIn Crunchbase

Kymera Therapeutics Overview

Headquarters: 500 North Beacon Street
Website: kymeratx.com
Industry: Biotechnology Research
Employees: 250
Founded: 2016
Funding: 250.8M
Company Email: Available in AeroLeads
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

About Kymera Therapeutics

Kymera is a clinical-stage biotechnology company pioneering the field of targeted protein degradation (TPD) to develop medicines that address critical health problems and have the potential to dramatically improve patients’ lives. Kymera is deploying TPD to address disease targets and pathways inaccessible with conventional therapeutics. Having advanced the first degrader into the clinic for immunological diseases, Kymera is focused on delivering oral small molecule degraders to provide a new generation of convenient, highly effective therapies for patients with these conditions. Founded in 2016, Kymera has been recognized as one of Boston’s top workplaces for the past several years.

Kymera Therapeutics Contact Details

People in AeroLeads: 4
With contact data: 4
Email contacts: 4; 100.0% coverage
Phone contacts: 4; 100.0% coverage

Kymera Therapeutics Org Chart

Sample employees and titles

Name	Title	Location	Contact
Bruce Booth	Partner at Atlas Venture	Wellesley, Massachusetts, United States	Email Phone
Brian Albarran		Boston, Massachusetts, United States	Email Phone
Melissa Hackel, Mba	Vice President of Finance	Greater Boston, United States	Email Phone
Juliet Williams		United States	Email Phone